Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Elanco Animal Health (ELAN) Stock Price & Analysis
287 Followers
ELAN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.88 - $16.88
Previous Close$13.41
Volume1.53M
Average Volume (3M)4.14M
Market Cap
$6.75B
Enterprise Value$12.03B
Total Cash (Recent Filing)$352.00M
Total Debt (Recent Filing)$5.77B
Price to Earnings (P/E)-5.4
Beta1.24
Next Earnings
May 08, 2024EPS Estimate
$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.50
Shares Outstanding492,970,011
10 Day Avg. Volume4,551,667
30 Day Avg. Volume4,136,645
Standard Deviation0.12
R-Squared0.31
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.00
Price to Sales (P/S)6.39
Price to Cash Flow (P/CF)10.70
P/FCF Ratio18.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit4.84
Enterprise Value/Ebitda-20.02
Forecast
1Y Price Target
$17.67Price Target Upside28.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Elanco Animal Health News
PremiumCompany Announcements
Elanco Enhances Board Governance with Strategic Appointments
Bulls Say, Bears Say
Bulls Say
Financial StrategyElanco plans to strengthen its financial position by using the proceeds from a recent deal to reduce debt, which is expected to improve its leverage and free cash flow.
Pipeline And RestructuringThe company's pipeline is on track with new product approvals on the horizon, coupled with a restructuring plan aimed at fostering innovation and cost savings.
Product LaunchesSales growth outlook is bolstered by upcoming product launches that could surpass current FY24 consensus estimates.
Bears Say
Business Segment PerformanceThe Aqua business, despite being a valuable part of the portfolio, receives less attention compared to more popular markets.
Company Track RecordThe company's limited innovation and inconsistent execution in recent times have led to underperformance compared to the market.
Financial PerformanceAdjusted EBITDA and Adjusted EPS fell short of market expectations, indicating potential underlying financial weaknesses.
---
Ownership Overview
0.76% Insiders
47.15% Mutual Funds
15.01% Other Institutional Investors
37.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $7.88 and its highest was $16.88 in the past 12 months.
What is Elanco Animal Health’s market cap?
Currently, no data Available
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is May 08, 2024 which is in 15 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Feb 26, 2024. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.105 by -$0.025.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is $0.26.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 492,970,000 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.08 in its last earnings report, missing expectations of $0.105. Following the earnings report the stock price went down -0.672%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Among the largest hedge funds holding Elanco Animal Health’s share is Dodge & Cox. It holds Elanco Animal Health’s shares valued at 1B.
---
Elanco Animal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.67 (28.98% Upside)
$17.67 (28.98% Upside)
Blogger Sentiment
Bullish
ELAN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $617.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.2%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.41%
12-Months-Change
Fundamentals
Return on Equity
-18.22%
Trailing 12-Months
Asset Growth
-7.29%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
---
ELAN Company Deck
---
ELAN Earnings Call
Q4 2024
0:00 / 0:00
---
ELAN Stock 12 Months Forecast
Average Price Target
$17.67
▲(28.98% Upside)
Technical Analysis
Best Analysts Covering ELAN
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+21.32%
reiterated a buy rating 2 months ago
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +21.32% per trade.
---